Rukobia 600 MG 12 HR Extended Release Oral Tablet

RxCUI: 2380551
RxNorm name: Rukobia 600 MG 12 HR Extended Release Oral Tablet
Display name: Rukobia 600 MG 12 HR Extended Release Oral Tablet
Full name: Rukobia 600 MG 12 HR Extended Release Oral Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:11

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Rukobia	FOSTEMSAVIR TROMETHAMINE	ViiV Healthcare Company	a21006b7-6d6f-4f06-81b4-17978756452b	2024-02-13	Warnings, Adverse reactions	Exact identifier rxcui: 2380551

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
a21006b7-6d6f-4f06-81b4-17978756452b	Rukobia 600 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR fostemsavir 600 MG Extended Release Oral Tablet [Rukobia] [SBD] · 12 HR fostemsavir 600 MG (equivalent to 725 MG fostemsavir tromethamine) Extended Release Oral Tablet [Rukobia] [SY] · Rukobia 600 MG 12 HR Extended Release Oral Tablet [SY]	4	8	These highlights do not include all the information needed to use RUKOBIA safely and effectively. See full prescribing information for RUKOBIA. RUKOBIA (fostemsavir) extended-release tablets, for oral use Initial U.S. Approval: 2020	20240213